NEW YORK (WKZO) -- British drugmaker AstraZeneca's stock prices are down, now that U.S. pharmaceutical giant Pfizer said it's done trying to buy the British firm. AstraZeneca's share price fell nearly 2.5-percent in early trading Tuesday. Pfizer made a number of offers to take over its smaller rival over the past month, but walked away after AstraZeneca turned down a final offer of 118-billion dollars from the world's biggest drugmaker.
Juke Van Oss 9:30 AM - 11:30 AM
On Air Now.